K Naidoo, J Ramruthan, M Reddy, M Reddy, R Lancaster
{"title":"用于追踪患者临床和病毒学结果的三线抗逆转录病毒治疗登记。","authors":"K Naidoo, J Ramruthan, M Reddy, M Reddy, R Lancaster","doi":"10.7196/SAMJ.v112i8.16695","DOIUrl":null,"url":null,"abstract":"<p><p>In 2021, South Africa (SA) had an estimated 7.8 million people living with HIV, of whom 5.6 million were receiving antiretroviral therapy (ART),[1] with 3.4 million on first-line ART, 145 000 on second-line ART (SLART) and >700 on third-line ART (TLART).</p>","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"511"},"PeriodicalIF":1.2000,"publicationDate":"2022-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A third-line antiretroviral therapy register to track patient clinical and virological outcomes.\",\"authors\":\"K Naidoo, J Ramruthan, M Reddy, M Reddy, R Lancaster\",\"doi\":\"10.7196/SAMJ.v112i8.16695\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>In 2021, South Africa (SA) had an estimated 7.8 million people living with HIV, of whom 5.6 million were receiving antiretroviral therapy (ART),[1] with 3.4 million on first-line ART, 145 000 on second-line ART (SLART) and >700 on third-line ART (TLART).</p>\",\"PeriodicalId\":520778,\"journal\":{\"name\":\"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde\",\"volume\":\" \",\"pages\":\"511\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2022-08-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.7196/SAMJ.v112i8.16695\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7196/SAMJ.v112i8.16695","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A third-line antiretroviral therapy register to track patient clinical and virological outcomes.
In 2021, South Africa (SA) had an estimated 7.8 million people living with HIV, of whom 5.6 million were receiving antiretroviral therapy (ART),[1] with 3.4 million on first-line ART, 145 000 on second-line ART (SLART) and >700 on third-line ART (TLART).
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
